Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds targeting central nervous system disorders. Its spirocyclic structure and functionalized side chain make it valuable for developing modulators of neurological receptors, particularly in the design of potential anticonvulsant and neuroprotective agents. The hydroxymethyl group allows for further chemical modifications, enabling the creation of prodrugs or ester derivatives to improve blood-brain barrier penetration. Also explored in medicinal chemistry for structure-activity relationship studies due to its rigid 3D architecture, which can enhance selectivity and metabolic stability in drug candidates.